Beth Faiman PhD (@bethfaiman) 's Twitter Profile
Beth Faiman PhD

@bethfaiman

Passionate about the diagnosis, management & care of patients with #multiplemyeloma #amyloidosis and #bloodcancer. And my family❤️. Tweets are my own.

ID: 2475877106

linkhttp://my.clevelandclinic.org/staff_directory/staff_display?doctorid=5953 calendar_today03-05-2014 19:01:36

3,3K Tweet

1,1K Followers

994 Following

Carol Whelan (@cjwhelan18) 's Twitter Profile Photo

Such an honour to be invited by AAN! Great to meet so many enthusiastic amyloidologists here. Perth is in great hands! #amyloidosisawareness

Raj Chakraborty (@rajshekharucms) 's Twitter Profile Photo

Teaching point in clinic today: DO NOT order "routine" monoclonal gammopathy workup in patients with osteoporosis! Excellent article on this by Eddie Cliff Manni Mohyuddin in The Lancet Haematology based on the iStopMM data! tinyurl.com/4n8x2vp7

Teaching point in clinic today: DO NOT order "routine" monoclonal gammopathy workup in patients with osteoporosis! 
Excellent article on this by <a href="/Eddie_Cliff/">Eddie Cliff</a> <a href="/ManniMD1/">Manni Mohyuddin</a> in <a href="/TheLancetHaem/">The Lancet Haematology</a> based on the <a href="/iStopMM/">iStopMM</a> data!
tinyurl.com/4n8x2vp7
Joshua Richter, MD, FACP (@joshuarichtermd) 's Twitter Profile Photo

Are you ready for controversies in myeloma? Getting excited to discuss what happens beyond immunotherapy with ⁦Claudio Cerchione⁩ ⁦COMy⁩ #mmsm ⁦Mohamad Mohty⁩ comy.cme-congresses.com/program/

Are you ready for controversies in myeloma?   Getting excited to discuss what happens beyond immunotherapy with ⁦<a href="/DottorClaudio/">Claudio Cerchione</a>⁩ ⁦<a href="/COMyCongress/">COMy</a>⁩ #mmsm ⁦<a href="/Mohty_EBMT/">Mohamad Mohty</a>⁩ comy.cme-congresses.com/program/
Tracy King (@mmkingt) 's Twitter Profile Photo

Exactly that 👇demonstrating all drugs can be toxic, treatment efficacy relies on capacity of pts to tolerate. More on dose/schedule reductions please

Faiz Anwer MD (@faizanwermd1) 's Twitter Profile Photo

Our new paper out now in Blood Reviews, on a potentially groundbreaking therapy for AL Amyloidosis, CAEL-101 sciencedirect.com/science/articl…

Our new paper out now in Blood Reviews, on a potentially groundbreaking therapy for AL Amyloidosis, CAEL-101

sciencedirect.com/science/articl…
Myeloma Society (@myeloma_society) 's Twitter Profile Photo

🚨Looking for a sign? Here’s your reminder to submit your abstract for #IMS25! 📄Guidelines + submission info: rb.gy/cb8sgq

🚨Looking for a sign? Here’s your reminder to submit your abstract for #IMS25! 📄Guidelines + submission info: rb.gy/cb8sgq
OncoDaily (@oncodaily) 's Twitter Profile Photo

15 Years Since We Changed Myeloma Care with Less Dexamethasone - Vincent Rajkumar Vincent Rajkumar ECOG-ACRIN Cancer Research Group oncodaily.com/science/vincen… #Cancer #CancerResearch #Medicine #Health #MedX #MedNews #MedEd #Dexamethasone #MyelomaCare #Oncology #OncoDaily

15 Years Since We Changed Myeloma Care with Less Dexamethasone - Vincent Rajkumar
<a href="/VincentRK/">Vincent Rajkumar</a> <a href="/eaonc/">ECOG-ACRIN Cancer Research Group</a> 

oncodaily.com/science/vincen…

#Cancer #CancerResearch #Medicine #Health #MedX #MedNews #MedEd #Dexamethasone #MyelomaCare #Oncology #OncoDaily
Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

The fascinating story of Thalidomide: how this most notorious drug on the planet, banned in the 1960s, made an incredible comeback and revolutionized the treatment of myeloma. I will also highlight one person whose role is not recognized: Without Dr. Leif Bergsagel there will

The fascinating story of Thalidomide: how this most notorious drug on the planet, banned in the 1960s, made an incredible comeback and revolutionized the treatment of myeloma. 

I will also highlight one person whose role is not recognized: Without Dr. Leif Bergsagel there will
Faiz Anwer MD (@faizanwermd1) 's Twitter Profile Photo

A unique toxicity linked with MOA with talquetamab use published by our team in BMJ Case Reports. casereports.bmj.com/content/17/11/…

A unique toxicity linked with MOA with talquetamab use published by our team in BMJ Case Reports. 

casereports.bmj.com/content/17/11/…